| Code |
| IKPM |
| Title |
| PT Ikapharmindo Putramas Tbk |
| Address |
| Head Office | : | | | Address | : | Jl. Pulogadung Raya No.29 Kawasan Industri Pulogadung | | | Jakarta Timur 13930 Indonesia | | Phone | : | (021) 460 0086 | | Fax | : | (021) 460 8865 | | E-mail | : | [email protected] | | Website | : | www.ikapharmindo.com | | Factory Location | : | | | | Jl. Raya Rancaekek KM.24 Kav. 5 BB RT02/RW07 Kawasan Industri Dwipapuri Abadi, | | | Desa Sawah Dadap, Kec. Cimanggung, Sumedang 40394 Jawa Barat | | Phone | : | - | | Fax | : | - | | E-mail | : | [email protected] | | Website | : | www.ikapharmindo.com |
|
| Background |
Business of The Company is pharmaceutical and personal care industry. |
| Business cp product |
Business of The Company is pharmaceutical and personal care industry. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | | | PT Distriversa Buanamas | Jakarta | Pharmaceutical wholesaler | 97.5 |
|
| Commissioners |
| President Commissioner | : Maudy Ratna Winata | | | Commissioner | : Titianus Winata | | | Independent Commissioner | : Susanto Lam | | | | | | Per 27 Jun 2023 | | |
|
| Directors |
| President Director | : Kartono | | | Director | : Ayi Saepudin | | | Director | : Eliza Arlena Winata | | | | | | Per 27 Jun 2023 | | |
|
| Underwriter |
|
| Share registrar |
|
| Share holders |
| Shareholders | Shares | | | | | PT Ikapharma Inti Mas | 1315950000 | 78.12 | | | | Dra. Maudy Ratna Winata | 14840000 | 0.88 | | | | Drs. Titianus Winata | 10460000 | 0.62 | | | | Augustina Winata | 3240000 | 0.19 | | | | Eliza Arlena Winata | 3240000 | 0.19 | | | | Public | 336932500 | 20 | | | | | | | | | As of Apr 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp. 16508-Nov-20231003369325001684662500 |
| Other infos |
Employee Stock Allocation/ESA 100,000 Shares |
| Created date |
| 2023-11-06 15:37:53 |
| Revised date |
| 2023-11-06 15:39:12 |
| Finance |
| PT Ikapharmindo Putramas Tbk |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|